试验撤回ClinicalTrials.gov(美国登记平台)来源日期:2019-05-30
Advance Provision of Medication Abortion
编号:NCT03829696登记状态:入组前撤回企业 / 申办者:University of California, San Francisco
药物 / 成分:Mifeprex® (Mifepristone 200 mg)、Misoprostol 800 mcg、ella® (ulipristal acetate emergency contraception 30 mg)、AccuHome® Pregnancy OTC Test
登记的停止原因(原文):The study is not proceeding at this time.
查看官方原始记录 ↗试验撤回ClinicalTrials.gov(美国登记平台)来源日期:2019-05-30
High Dose Ascorbic Acid and Nanoparticle Paclitaxel Protein Bound and Cisplatin and Gemcitabine (AA NABPLAGEM) in Patients Who Have Metastatic Pancreatic Cancer
编号:NCT03908333登记状态:入组前撤回企业 / 申办者:Medical College of Wisconsin
药物 / 成分:Ascorbic Acid、Paclitaxel protein-bound、Cisplatin、Gemcitabine
登记的停止原因(原文):Request to close per funding sponsor. Site not moving forward with trial.
查看官方原始记录 ↗试验撤回ClinicalTrials.gov(美国登记平台)来源日期:2019-05-29
Safety and Efficacy of Gabapentin for Neuropathic Pain in Fabry Disease
编号:NCT01588314登记状态:入组前撤回企业 / 申办者:University of Minnesota
药物 / 成分:Gabapentin、placebo
登记的停止原因(原文):No patients were enrolled. No data \& no study results to report.
查看官方原始记录 ↗试验撤回ClinicalTrials.gov(美国登记平台)来源日期:2019-05-29
Platelet Function With Various Storage Techniques
编号:NCT03338660登记状态:入组前撤回企业 / 申办者:Northwell Health
药物 / 成分:Infusion of Platelets、Infusion of Platelets、Placebo
登记的停止原因(原文):Unable to begin study due to funding. PI has left organization.
查看官方原始记录 ↗试验撤回ClinicalTrials.gov(美国登记平台)来源日期:2019-05-28
A Study of Safety and Tolerability of NOX66 in Healthy Volunteers
编号:NCT03780465登记状态:入组前撤回企业 / 申办者:Noxopharm Limited
药物 / 成分:Oral idronoxil suspension、NOX66 (A)、NOX66 (B)
登记的停止原因(原文):Decision to obtain PK data at a later date
查看官方原始记录 ↗试验撤回ClinicalTrials.gov(美国登记平台)来源日期:2019-05-23
Effect of Cyclodextrin on Sensory Nerve Activity: A Novel Anti-tussive Therapy
编号:NCT01960621登记状态:入组前撤回企业 / 申办者:Imperial College London
药物 / 成分:cyclodextrin
登记的停止原因(原文):Study has not been able to start due to difficulty in obtaining an intravenous formulation of cyclodextrin (intravenous 2HPBCD) suitable for man
查看官方原始记录 ↗试验撤回ClinicalTrials.gov(美国登记平台)来源日期:2019-05-23
Duration of Analgesia With Dexmedetomidine and Ropivacaine in Brachial Plexus Block
编号:NCT03385967登记状态:入组前撤回企业 / 申办者:University of Florida
药物 / 成分:Dexmedetomidine、ropivacaine
登记的停止原因(原文):PI is leaving the University of Florida
查看官方原始记录 ↗试验撤回ClinicalTrials.gov(美国登记平台)来源日期:2019-05-23
Novel Collagen Scaffold vs Conventional Scaffold in Regeneration of Human Dental Pulp Tissue
编号:NCT03613090登记状态:入组前撤回企业 / 申办者:University of Alabama at Birmingham
药物 / 成分:Collagen-hydroxyapatite scaffold (Syn-Oss)、Collagen Scaffold (Colla-Plug)
登记的停止原因(原文):Withdrawn-was not approved by IRB
查看官方原始记录 ↗试验撤回ClinicalTrials.gov(美国登记平台)来源日期:2019-05-22
A Study of Stellate Ganglion Block and / or Reserpine in Group 2 Pulmonary Hypertension
编号:NCT02684786登记状态:入组前撤回企业 / 申办者:Mayo Clinic
药物 / 成分:reserpine、stellate ganglion block、lidocaine
登记的停止原因(原文):IRB did not approve
查看官方原始记录 ↗试验撤回ClinicalTrials.gov(美国登记平台)来源日期:2019-05-22
Oligometastases of the LIVer Treated With Chemotherapy With ou Without Extracranial Stereotactic Body Radiation Therapy in Patients With Colorectal Cancer
编号:NCT03532204登记状态:入组前撤回企业 / 申办者:UNICANCER
药物 / 成分:SBRT、Chemotherapy
登记的停止原因(原文):no participants enrolled
查看官方原始记录 ↗